Literature DB >> 32844298

Fetal Echocardiography is Useful for Screening Fetuses with a Family History of Cardiomyopathy.

Nicholas B Zaban1,2, Robert K Darragh1, John J Parent3,4.   

Abstract

We screened all fetal echocardiograms performed at our institution for the past 5 years for the indication of family history of cardiomyopathy. Twenty-six patients were identified who had fetal echocardiograms performed due to a family history of cardiomyopathy. Three out of 26 patients (11.5%) had findings of decreased ventricular function and dilation consistent with cardiomyopathy. All who had cardiomyopathy on fetal echocardiography had parents with genetic mutations (2 maternal, 1 paternal), including one mother who had a cardiac transplant at age 8 for dilated cardiomyopathy. All 3 affected infants had prenatal planning for high level care and were transferred to our facility immediately after birth for cardiology evaluation and management. 2 patients required inotropic support in the newborn period. One patient was transplanted at age 2 months. One patient required ECMO support for one week and initially recovered, but subsequently required mechanical support and listing for heart transplant. We recommend patients with a strong family history of cardiomyopathy in either parent, especially those with known genetic mutations associated with cardiomyopathy, have fetal echocardiograms performed.

Entities:  

Keywords:  Cardiomyopathy; Fetal echocardiography; Non-compaction cardiomyopathy; Screening

Year:  2020        PMID: 32844298     DOI: 10.1007/s00246-020-02439-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  23 in total

Review 1.  Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association.

Authors:  Mary T Donofrio; Anita J Moon-Grady; Lisa K Hornberger; Joshua A Copel; Mark S Sklansky; Alfred Abuhamad; Bettina F Cuneo; James C Huhta; Richard A Jonas; Anita Krishnan; Stephanie Lacey; Wesley Lee; Erik C Michelfelder; Gwen R Rempel; Norman H Silverman; Thomas L Spray; Janette F Strasburger; Wayne Tworetzky; Jack Rychik
Journal:  Circulation       Date:  2014-04-24       Impact factor: 29.690

2.  Spectrum and outcome of primary cardiomyopathies diagnosed during fetal life.

Authors:  Roland Weber; Paul Kantor; David Chitayat; Mark K Friedberg; Fraser Golding; Luc Mertens; Lynne E Nield; Greg Ryan; Mike Seed; Shi-Joon Yoo; Cedric Manlhiot; Edgar Jaeggi
Journal:  JACC Heart Fail       Date:  2014-07-09       Impact factor: 12.035

3.  Dilated cardiomyopathy presenting during fetal life.

Authors:  Sivasubramonian Sivasankaran; Gurleen K Sharland; John M Simpson
Journal:  Cardiol Young       Date:  2005-08       Impact factor: 1.093

4.  Cardiac function assessment in patients with family history of nonhypertrophic cardiomyopathy: a prenatal and postnatal study.

Authors:  S R F F Pedra; L K Hornberger; S M Leal; G P Taylor; J F Smallhorn
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

5.  The incidence of pediatric cardiomyopathy in two regions of the United States.

Authors:  Steven E Lipshultz; Lynn A Sleeper; Jeffrey A Towbin; April M Lowe; E John Orav; Gerald F Cox; Paul R Lurie; Kristina L McCoy; Melissa A McDonald; Jane E Messere; Steven D Colan
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  A possible increase in the incidence of congenital heart defects among the offspring of affected parents.

Authors:  V Rose; R J Gold; G Lindsay; M Allen
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

7.  A second-generation study of 427 probands with congenital heart defects and their 837 children.

Authors:  R Whittemore; J A Wells; X Castellsague
Journal:  J Am Coll Cardiol       Date:  1994-05       Impact factor: 24.094

8.  Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience.

Authors:  Karin Y van Spaendonck-Zwarts; Ingrid A W van Rijsingen; Maarten P van den Berg; Ronald H Lekanne Deprez; Jan G Post; Anneke M van Mil; Folkert W Asselbergs; Imke Christiaans; Irene M van Langen; Arthur A M Wilde; Rudolf A de Boer; Jan D H Jongbloed; Yigal M Pinto; J Peter van Tintelen
Journal:  Eur J Heart Fail       Date:  2013-01-24       Impact factor: 15.534

9.  Maternal transmission of congenital heart diseases: new recurrence risk figures and the questions of cytoplasmic inheritance and vulnerability to teratogens.

Authors:  J J Nora; A H Nora
Journal:  Am J Cardiol       Date:  1987-02-15       Impact factor: 2.778

Review 10.  Diagnosis and management of fetal heart failure.

Authors:  Varsha Thakur; Jean-Claude Fouron; Luc Mertens; Edgar T Jaeggi
Journal:  Can J Cardiol       Date:  2013-05-08       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.